Standardization of a well-controlled in vivo mouse model of thrombus formation induced by mechanical injury

Thromb Res. 2016 May:141:49-57. doi: 10.1016/j.thromres.2016.02.032. Epub 2016 Mar 2.

Abstract

Objective: Vascular plug formation by mechanical injury that exposes abundant extracellular matrix is an ideal model to mimic thrombus formation. The objective of this study was to standardize our previously established in vivo mouse model of thrombus formation induced by mechanical injury.

Results: The mechanical injury was exerted by pinching the abdominal aorta with hemostatic forceps for either 15 (moderate injury) or 60 (severe injury) seconds. Thrombus formation was monitored for 20min in real time using a fluorescent microscope coupled to a CCD camera. In the moderate injury, thrombus formation peaked at approximately 1min after injury and resolved within 3min, with the mean AUC (area under the curve) of 165.2±17.29mm(2), whereas a larger thrombus was observed upon the severe injury, with the mean AUC of 600.5±37.77mm(2). Using scanning electron microscopy and HE staining, a complete deformation of the endothelium in the moderate injury model and the exposure of the media in the severe injury model were observed. The model was also evaluate for its application on the effects of antithrombotic drugs targeting GP IIb-IIIa (eptifibatide), ADP receptor P2Y1 (MRS2500) and P2Y12 (clopidogrel), and thrombin (hirudin) on thrombus formation.

Conclusions: We have improved a vascular injury model with optimal reproducibility and feasibility that allows evaluating the effect of anti-thrombotic drugs on thrombus formation in vivo.

Keywords: Animal model; Anti-thrombotic; Mechanical injury; Thrombosis.

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / injuries*
  • Aorta / pathology*
  • Clopidogrel
  • Disease Models, Animal
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology
  • Eptifibatide
  • Hirudin Therapy / methods
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Peptides / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Stress, Mechanical
  • Thrombosis / drug therapy
  • Thrombosis / etiology*
  • Thrombosis / pathology*
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Peptides
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Clopidogrel
  • Eptifibatide
  • Ticlopidine